180 related articles for article (PubMed ID: 22506673)
1. Probing the caveolin-1 P132L mutant: critical insights into its oligomeric behavior and structure.
Rieth MD; Lee J; Glover KJ
Biochemistry; 2012 May; 51(18):3911-8. PubMed ID: 22506673
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the P132L disease mutation in caveolin-1 reveals its role in the assembly of oligomeric complexes.
Han B; Gulsevin A; Connolly S; Wang T; Meyer B; Porta J; Tiwari A; Deng A; Chang L; Peskova Y; Mchaourab HS; Karakas E; Ohi MD; Meiler J; Kenworthy AK
J Biol Chem; 2023 Apr; 299(4):104574. PubMed ID: 36870682
[TBL] [Abstract][Full Text] [Related]
3. The transmembrane domain of caveolin-1 exhibits a helix-break-helix structure.
Lee J; Glover KJ
Biochim Biophys Acta; 2012 May; 1818(5):1158-64. PubMed ID: 22240009
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
5. Tagging strategies strongly affect the fate of overexpressed caveolin-1.
Han B; Tiwari A; Kenworthy AK
Traffic; 2015 Apr; 16(4):417-38. PubMed ID: 25639341
[TBL] [Abstract][Full Text] [Related]
6. Secondary Structure Analysis of a Functional Construct of Caveolin-1 Reveals a Long C-Terminal Helix.
Plucinsky SM; Glover KJ
Biophys J; 2015 Oct; 109(8):1686-8. PubMed ID: 26488659
[TBL] [Abstract][Full Text] [Related]
7. Non-existence of caveolin-1 gene mutations in human breast cancer.
Patani N; Lambros MB; Natrajan R; Dedes KJ; Geyer FC; Ward E; Martin LA; Dowsett M; Reis-Filho JS
Breast Cancer Res Treat; 2012 Jan; 131(1):307-10. PubMed ID: 21909981
[TBL] [Abstract][Full Text] [Related]
8. Src-dependent phosphorylation of caveolin-1 Tyr-14 promotes swelling and release of caveolae.
Zimnicka AM; Husain YS; Shajahan AN; Sverdlov M; Chaga O; Chen Z; Toth PT; Klomp J; Karginov AV; Tiruppathi C; Malik AB; Minshall RD
Mol Biol Cell; 2016 Jul; 27(13):2090-106. PubMed ID: 27170175
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Caveolin-induced Membrane Curvature.
Ariotti N; Rae J; Leneva N; Ferguson C; Loo D; Okano S; Hill MM; Walser P; Collins BM; Parton RG
J Biol Chem; 2015 Oct; 290(41):24875-90. PubMed ID: 26304117
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome.
Zheng YZ; Boscher C; Inder KL; Fairbank M; Loo D; Hill MM; Nabi IR; Foster LJ
Mol Cell Proteomics; 2011 Oct; 10(10):M110.007146. PubMed ID: 21753190
[TBL] [Abstract][Full Text] [Related]
11. Structural and dynamic properties of juxta-membrane segments of caveolin-1 and caveolin-2 at the membrane interface.
Le Lan C; Gallay J; Vincent M; Neumann JM; de Foresta B; Jamin N
Eur Biophys J; 2010 Jan; 39(2):307-25. PubMed ID: 19847421
[TBL] [Abstract][Full Text] [Related]
12. The role of proline in the membrane re-entrant helix of caveolin-1.
Aoki S; Thomas A; Decaffmeyer M; Brasseur R; Epand RM
J Biol Chem; 2010 Oct; 285(43):33371-33380. PubMed ID: 20729193
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of Caveolin-1 into Artificial Lipid Membrane: Characterization by Transmission Electron Microscopy and Solid-State Nuclear Magnetic Resonance.
Zhang Y; Zhang X; Kong W; Wang S
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684779
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 hydrophobic segment peptides insertion into membrane mimetic systems: role of proline residue.
Aoki S; Epand RM
Biochim Biophys Acta; 2012 Jan; 1818(1):12-8. PubMed ID: 21958667
[TBL] [Abstract][Full Text] [Related]
15. Absence of the caveolin-1 P132L mutation in cancers of the breast and other organs.
Koike S; Kodera Y; Nakao A; Iwata H; Yatabe Y
J Mol Diagn; 2010 Sep; 12(5):712-7. PubMed ID: 20581046
[TBL] [Abstract][Full Text] [Related]
16. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.
Mercier I; Bryant KG; Sotgia F; Bonuccelli G; Witkiewicz AK; Dasgupta A; Jasmin JF; Pestell RG; Lisanti MP
Cell Cycle; 2009 May; 8(9):1396-401. PubMed ID: 19342880
[TBL] [Abstract][Full Text] [Related]
17. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells.
Orlichenko L; Huang B; Krueger E; McNiven MA
J Biol Chem; 2006 Feb; 281(8):4570-9. PubMed ID: 16332692
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy.
Han B; Copeland CA; Kawano Y; Rosenzweig EB; Austin ED; Shahmirzadi L; Tang S; Raghunathan K; Chung WK; Kenworthy AK
Traffic; 2016 Dec; 17(12):1297-1312. PubMed ID: 27717241
[TBL] [Abstract][Full Text] [Related]
19. Scaffolds and the scaffolding domain: an alternative paradigm for caveolin-1 signaling.
Lim JE; Bernatchez P; Nabi IR
Biochem Soc Trans; 2024 Apr; 52(2):947-959. PubMed ID: 38526159
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the topology, structure, and oligomerization of caveolin: a building block of caveolae.
Root KT; Plucinsky SM; Glover KJ
Curr Top Membr; 2015; 75():305-36. PubMed ID: 26015287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
